Nanovaccine Institute (Iowa State University)


The Nanovaccine Institute, established at Iowa State University in 2017, is a national transdisciplinary research consortium focused on advancing nano-based technologies to treat and prevent diseases. The institute aims to revolutionize public health outcomes through the design and promotion of nano-based vaccines and therapeutics.

Industries

Advanced Materials
Aerospace
AgTech
Agriculture
Biomass Energy
Catering
Chemical
Communities
Consulting
Data Visualization
E-Learning
EdTech
Education
Emergency Medicine
Energy
Environmental Consulting
Family
Food Delivery
Food and Beverage
Government
Health Care
Higher Education
Industrial Engineering
Infrastructure
Law Enforcement
Local
Manufacturing
Mechanical Engineering
Mental Health
Non Profit
Nutrition
Project Management
Public Relations
Public Safety
Restaurants
STEM Education
Security
Simulation
Software
Sporting Goods
Sports
Sustainability
Transportation
Universities

Nr. of Employees

Very Large (1000+)

Nanovaccine Institute (Iowa State University)


Products

Universal influenza intranasal powder nanovaccine (preclinical)

A nanoparticle-based intranasal powder vaccine candidate intended to provide broad protection against influenza strains, designed for single-dose administration, ambient-temperature stability, and needle-free delivery.

Amphiphilic polyanhydride nanomedicines for antimicrobial-resistant pathogens (preclinical)

Nanoparticle formulations designed to deliver antimicrobials across protective barriers of parasites and resistant bacteria to improve efficacy and reduce systemic side effects.

Monoclonal antibody-based quantitative enzyme immunoassay for α-synuclein (research assay)

A quantitative enzyme immunoassay developed with specific monoclonal antibodies to detect pathological aggregates of α-synuclein for early diagnosis and research in neurodegenerative disease.


Services

Bench-to-bedside translational support including preclinical study design, pre-IND planning, and coordination with clinical and regulatory partners.

Coordination of multi-institution collaborations, industry engagement, and support for patenting and licensing pathways toward commercialization.

Organization of an annual scientific conference, production of a podcast series, and distribution of quarterly newsletters to share research updates and foster community engagement.

Institutional core facilities and research staff that support nanoparticle design, formulation, and preclinical testing workflows.

Expertise Areas

  • Immunology
  • Nanotechnology
  • Materials science
  • Microbiology
  • Show More (8)

Key Technologies

  • Polymeric nanoparticles
  • Spray-drying nanoparticle manufacture
  • Intranasal powder vaccine formulation
  • Mucosal vaccine delivery
  • Show More (9)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.